EFFECT OF CYCLOSPORIN A ON HUMAN LYMPHOCYTE RESPONSES IN VITRO. I: CSA ALLOWS FOR THE EXPRESSION OF ALLOANTIGEN-ACTIVATED SUPPRESSOR CELLS WHILE PREFERENTIALLY INHIBITING THE INDUCTION OF CYTOLYTIC EFFECTOR LYMPHOCYTES IN MLRHESS AD; TUTSCHKA PJ.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 6; PP. 2601-2608; BIBL. 29 REF.Article

MARROW TRANSPLANTATION IN THE BUSULFAN-TREATED RAT: PRECLINICAL MODEL OF APLASTICS ANEMIA = TRANSPLANTATION DE MOELLE OSSEUSE CHEZ LE RAT TRAITE PAR LE BUSULFAN: MODELE PRECLINIQUE DE L'ANEMIE APLASIQUESANTOS GW; TUTSCHKA PJ.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 53; NO 6; PP. 1781-1785; BIBL. 22REF.Article

BONE MARROW TRANSPLANTATION IN THE BUSULFAN-TREATED RAT. II. EFFECT OF CYCLOPHOSPHAMIDE AND ANTITHYMIC SERUM ON THE PRESENSITIZED STATE = TRANSPLANTATION DE MOELLE CHEZ LE RAT TRAITE PAR LE BUSULFAN. II. EFFET DU CYCLOPHOSPHAMIDE ET DU SERUM ANTITHYMOCYTES SUR L'ETAT DE PRESENSIBILISATIONTUTSCHKA PJ; SANTOS GW.1975; TRANSPLANTATION; U.S.A.; DA. 1975; VOL. 20; NO 2; PP. 116-122; BIBL. 22 REF.Article

EFFECT OF BUSULFAN ON ANTIBODY PRODUCTION AND SKIN ALLOGRAFT SURVIVAL IN THE RATSANTOS GW; TUTSCHKA PJ.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 53; NO 6; PP. 1775-1780; BIBL. 33REF.Article

EFFECT OF CYCLOSPORIN A ON HUMAN LYMPHOCYTE RESPONSES IN VITRO. II: INDUCTION OF SPECIFIC ALLOANTIGEN UNRESPONSIVENESS MEDIATED BY A NYLON WOOL ADHERENT SUPPRESSOR CELLHESS AD; TUTSCHKA PJ; SANTOS GW et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 126; NO 3; PP. 961-968; BIBL. 33 REF.Article

SUPPRESSOR CELLS IN TRANSPLANTATION TOLERANCE. I: SUPPRESSOR CELLS IN THE MECHANISM OF TOLERANCE IN RADIATION CHIMERASTUTSCHKA PJ; HESS AD; BESCHORNER WE et al.1981; TRANSPLANTATION; ISSN 0041-1337; USA; DA. 1981; VOL. 32; NO 3; PP. 203-209; BIBL. 49 REF.Article

DEFICIENCY OF INTESTINAL IMMUNITY WITH GRAFT-VS.-HOST DISEASE IN HUMANSBESCHORNER WE; YARDLEY JH; TUTSCHKA PJ et al.1981; J. INFECT. DIS.; ISSN 0022-1899; USA; DA. 1981; VOL. 144; NO 1; PP. 38-46; BIBL. 36 REF.Article

USE OF CYCLOSPORIN A IN ALLOGENEIC BONE MARROW TRANSPLANTATION IN THE RATTUTSCHKA PJ; BESCHORNER WE; ALLISON AC et al.1979; NATURE; GBR; DA. 1979; VOL. 280; NO 5718; PP. 148-151; BIBL. 20 REF.Article

THE EYE IN BONE MARROW TRANSPLANTATION. I: CLINICAL STUDYHIRST LW; JABS DA; TUTSCHKA PJ et al.1983; ARCHIVES OF OPHTHALMOLOGY; ISSN 0003-9950; USA; DA. 1983; VOL. 101; NO 4; PP. 580-584; BIBL. 19 REF.Article

SUPPRESSOR CELLS IN TRANSPLANTATION TOLERANCE. II: MATURATION OF SUPPRESSOR CELLS IN THE BONE MARROW CHIMERATUTSCHKA PJ; KI PF; BESCHORNER WE et al.1981; TRANSPLANTATION; ISSN 0041-1337; USA; DA. 1981; VOL. 32; NO 4; PP. 321-325; BIBL. 27 REF.Article

LYMPHOCYTIC BRONCHITIS ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF BONE-MARROW TRANSPLANTSBESCHORNER WE; SARAL R; HUTCHINS GM et al.1978; NEW ENGL. J. MED.; USA; DA. 1978; VOL. 299; NO 19; PP. 1030-1036; BIBL. 26 REF.Article

PATHOLOGY OF THE LIVER WITH BONE MARROW TRANSPLANTATION. EFFECTS OF BUSULFAN, CARMUSTINE, ACUTE GRAFT-VERSUS-HOST DISEASE AND CYTOMEGALOVIRUS INFECTIONBESCHORNER WE; PINO J; BOITNOTT JK et al.1980; AM. J. PATHOL.; ISSN 0002-9440; USA; DA. 1980; VOL. 99; NO 2; PP. 369-386; BIBL. 53 REF.Article

THE EYE IN BONE MARROW TRANSPLANTATION. II: HISTOPATHOLOGYJABS DA; HIRST LW; GREEN WR et al.1983; ARCHIVES OF OPHTHALMOLOGY; ISSN 0003-9950; USA; DA. 1983; VOL. 101; NO 4; PP. 585-590; BIBL. 22 REF.Article

OCULAR MANIFESTATIONS OF GRAFT-VS-HOST DISEASEFRANKLIN RM; KENYON KR; TUTSCHKA PJ et al.1983; OPHTHALMOLOGY (ROCHESTER); ISSN 0161-6420; USA; DA. 1983; VOL. 90; NO 1; PP. 4-13; BIBL. 21 REF.Article

BONE MARROW TRANSPLANTATION WITH MAJOR ABO BLOOD GROUP INCOMPATIBILITY USING ERYTHROCYTE DEPLETION OF MARROW PRIOR TO INFUSIONBRAINE HG; SENSENBRENNE LL; WRIGHT SK et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 60; NO 2; PP. 420-425; BIBL. 12 REF.Article

SYSTEMIC IRRADIATION FOR SELECTED STAGE IV AND RECURRENT PEDIATRIC SOLID TUMORS: METHOD, TOXICITY, AND PRELIMINARY RESULTSWHARAM MD; KAIZER H; LEVENTHAL BG et al.1980; INTERNATION. J. RAD. ONCOL. BIOL. PHYS.; USA; DA. 1980; VOL. 6; NO 2; PP. 217-223; BIBL. 24 REF.Article

THE USE OF CYCLOPHOSPHAMIDE FOR CLINICAL MARROW TRANSPLANTATION = L'EMPLOI DU CYCLOPHOSPHAMIDE POUR LA TRANSPLANTATION DE MOELLE EN CLINIQUESANTOS GW; SENSENBRENNER LL; BURKE PJ et al.1972; TRANSPLANT. PROC.,; U.S.A.; DA. 1972; VOL. 4; NO 4; PP. 559-564; BIBL. 13REF.Serial Issue

PREPARATIVE REGIMENS FOR MARROW TRANSPLANTATION IN ACUTE LEUKEMIA AND APLASTIC ANEMIA: BALTIMORE EXPERIENCETUTSCHKA PJ; ELFENBEIN GJ; SENSENBRENNER LL et al.1980; AM. J. PEDIATR. HEMATOL.-ONCOL.; USA; DA. 1980; VOL. 2; NO 4; PP. 363-370; BIBL. 29 REF.Article

THE USE OF FRACTIONATED RADIOTHERAPY AS PREPARATION FOR ALLOGENEIC BONE MARROW TRANSPLANTATIONLICHTER AS; TUTSCHKA PJ; WHARAM MD et al.1979; TRANSPLANT. PROC.; USA; DA. 1979; VOL. 11; NO 2; PP. 1492-1494; BIBL. 18 REF.Article

THE IMMUNE SYSTEM IN 40 APLASTIC ANEMIA PATIENTS RECEIVING CONVENTIONAL THERAPYELFENBEIN GJ; KALLMAN CH; TUTSCHKA PJ et al.1979; BLOOD; USA; DA. 1979; VOL. 53; NO 4; PP. 652-665; BIBL. 49 REF.Article

ALLOGENIC MARROW GRAFTS IN MAN USING CYCLOPHOSPHAMIDESANTOS GW; SENSENBRENNER LL; BURKE PJ et al.1974; TRANSPLANT. PROC.; U.S.A.; DA. 1974; VOL. 6; NO 4; PP. 345-348; BIBL. 5REF.; (BONE-MARROW TRANSPLANT. CURR. RESULTS PROPSPECTS. ANNU. MEET. INT. GROUP BONE-MARROW TRANSPLANT.; PARIS, FR.; 1973)Conference Paper